A Mobile App for Tracking Time Burden of Pancreatic Cancer Treatment: A Single-Arm Feasibility Study
Trial Snapshot
- Phase
- Not Applicable
- Status
- Recruiting
- Enrollment
- 30
- Locations
- 1
Study Overview
Brief Summary
This clinical trial tests the feasibility of using the MyCap mobile application (app) for tracking time burden from treatment for patients with pancreatic cancer. Pancreatic cancer is best treated with many care teams, such as medical oncology and surgery, requiring patients to dedicate significant time coordinating appointments among different doctors. This time commitment is referred to as time toxicity, defined as the time spent undergoing cancer-related medical care, such as emergency visits, ambulatory care, lab and infusion visits, hospitalizations, and the commuting and waiting times associated with each. At present, time toxicity is still understudied within the medical literature, with no gold standard established for the method of measurement. The MyCap mobile app may be a feasible way to track the time burden from treatment for patients with pancreatic cancer.
Detailed Description
PRIMARY OBJECTIVE:
I. To assess the feasibility of utilizing a mobile application for patients to self-track the time burden associated with undergoing pancreatic cancer treatment.
OUTLINE:
Patients download the MyCap app onto their phone and fill out a daily time log in the app for 8 weeks.
Study Design
- Study Type
- Interventional
- Allocation
- Na
- Intervention Model
- Single Group
- Primary Purpose
- Health Services Research
- Masking
- None
Eligibility Criteria
- Ages
- 18 Years to — (Adult, Older Adult)
- Sex
- All
- Accepts Healthy Volunteers
- No
Inclusion Criteria
- •Adults ≥ 18 years old
- •Diagnosed with pancreatic adenocarcinoma undergoing active treatment or planning to start active treatment within the next 30 days
- •English speaking
- •Access to a smartphone (Android or iOS)
Exclusion Criteria
- •Prisoners
- •Patients undergoing cancer surveillance
Investigators
Pamela Lu
Principal Investigator
Ohio State University Comprehensive Cancer Center